JPH0581566B2 - - Google Patents
Info
- Publication number
- JPH0581566B2 JPH0581566B2 JP60177355A JP17735585A JPH0581566B2 JP H0581566 B2 JPH0581566 B2 JP H0581566B2 JP 60177355 A JP60177355 A JP 60177355A JP 17735585 A JP17735585 A JP 17735585A JP H0581566 B2 JPH0581566 B2 JP H0581566B2
- Authority
- JP
- Japan
- Prior art keywords
- glucosamine
- skin
- cells
- whitening
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 claims description 14
- 150000002301 glucosamine derivatives Chemical class 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 2
- 150000002336 glycosamine derivatives Chemical class 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 description 23
- 210000003491 skin Anatomy 0.000 description 19
- 210000004694 pigment cell Anatomy 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 9
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- -1 hydrochloride Tetra-O-propanoyl-glucosamine hydrochloride N-octanoyl-glucosamine N-acetyl-1,3,4,6-tetra-O- Propionylglucosamine N-acetyl-1,3,4,6-tetra-O- Butyrylglucosamine Chemical compound 0.000 description 8
- 229960002442 glucosamine Drugs 0.000 description 7
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 6
- 229960004705 kojic acid Drugs 0.000 description 6
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 206010040829 Skin discolouration Diseases 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229940117916 cinnamic aldehyde Drugs 0.000 description 4
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- 201000001441 melanoma Diseases 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 206010014970 Ephelides Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 230000000684 melanotic effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 206010047642 Vitiligo Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 231100001083 no cytotoxicity Toxicity 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- ZRAWPYYLRZSVEU-GNMOMJPPSA-N [(2r,3s,4r,5r)-3,4,6-triacetyloxy-5-aminooxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1OC(OC(C)=O)[C@H](N)[C@@H](OC(C)=O)[C@@H]1OC(C)=O ZRAWPYYLRZSVEU-GNMOMJPPSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000010218 electron microscopic analysis Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- DOPGJHMBFNGSTK-NKLQQJLKSA-N n-[(3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]octanamide Chemical compound CCCCCCCC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O DOPGJHMBFNGSTK-NKLQQJLKSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17735585A JPS6236306A (ja) | 1985-08-12 | 1985-08-12 | 色白化粧料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17735585A JPS6236306A (ja) | 1985-08-12 | 1985-08-12 | 色白化粧料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6236306A JPS6236306A (ja) | 1987-02-17 |
| JPH0581566B2 true JPH0581566B2 (de) | 1993-11-15 |
Family
ID=16029516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17735585A Granted JPS6236306A (ja) | 1985-08-12 | 1985-08-12 | 色白化粧料 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6236306A (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2565513B2 (ja) * | 1987-09-25 | 1996-12-18 | 三省製薬株式会社 | メラニン生成抑制外用薬剤 |
| JPH02262504A (ja) * | 1988-12-24 | 1990-10-25 | Rinjiro Saruno | メラニン色素生成抑制剤 |
| JP2585094B2 (ja) * | 1989-03-16 | 1997-02-26 | 株式会社 コーセー | 化粧料 |
| JPH0311019A (ja) * | 1989-06-08 | 1991-01-18 | Sansho Seiyaku Co Ltd | メラニン生成抑制外用剤 |
| KR940000166B1 (ko) * | 1989-11-09 | 1994-01-08 | 니혼다바고 상교오 가부시기가이샤 | 신규 글루코사민 유도체 및 이것을 막 구성성분으로서 함유한 리포솜 |
| WO1991007416A1 (fr) * | 1989-11-09 | 1991-05-30 | Japan Tobacco Inc. | Nouveau derive de glucosamine et liposome le contenant en tant que composant de membrane |
| KR940004071B1 (ko) * | 1990-04-12 | 1994-05-11 | 니홍 다바꼬 상교 가부시끼가이샤 | 4,6-o-히드록시포스포릴글루코사민 유도체 |
| WO2001001993A1 (en) * | 1999-07-02 | 2001-01-11 | Greither, Peter | A formulation of glucosamine sulphate |
| EP1941863A3 (de) * | 2002-07-25 | 2008-12-31 | Lion Corporation | Zusammensetzung zur externen Zubereitung |
| DE60225077D1 (de) | 2002-07-25 | 2008-03-27 | Lion Corp | Topisches präparat |
| CN101177438B (zh) * | 2002-10-09 | 2012-05-23 | 花王株式会社 | N-乙酰葡糖胺衍生物及其用途 |
| US7393937B2 (en) | 2002-10-09 | 2008-07-01 | Kao Corporation | N-acetylglucosamine derivatives and use thereof |
| WO2005074879A1 (ja) * | 2004-02-04 | 2005-08-18 | Kao Corporation | シワ改善剤 |
| EP2094277A4 (de) * | 2006-10-20 | 2010-01-20 | Kim Soo Youl | Zusammensetzung zur behandlung von atopischer dermatitis mit glucosamin und seinen derivaten und verfahren zur behandlung von atopischer dermatitis damit |
| JP5258993B1 (ja) * | 2012-03-29 | 2013-08-07 | 株式会社 資生堂 | ヘパラン硫酸産生促進剤 |
| US11241374B2 (en) * | 2018-06-28 | 2022-02-08 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating skin conditions using light and glucosamine hydrochloride |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4920762A (de) * | 1972-06-20 | 1974-02-23 | ||
| JPS5913708A (ja) * | 1982-07-14 | 1984-01-24 | Shiseido Co Ltd | 化粧料 |
| JPS59157009A (ja) * | 1983-02-25 | 1984-09-06 | Yakurigaku Chuo Kenkyusho:Kk | メラニン生成抑制外用剤 |
-
1985
- 1985-08-12 JP JP17735585A patent/JPS6236306A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4920762A (de) * | 1972-06-20 | 1974-02-23 | ||
| JPS5913708A (ja) * | 1982-07-14 | 1984-01-24 | Shiseido Co Ltd | 化粧料 |
| JPS59157009A (ja) * | 1983-02-25 | 1984-09-06 | Yakurigaku Chuo Kenkyusho:Kk | メラニン生成抑制外用剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6236306A (ja) | 1987-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4025546B2 (ja) | 美肌剤、皮膚の抗老化剤、美白剤および皮膚外用剤 | |
| JPH0581566B2 (de) | ||
| JP4564471B2 (ja) | 外用に適する組成物 | |
| US5601806A (en) | Methods for scavenging active oxygen compounds and preventing damage from ultra violet B rays using taurine analogues | |
| JP2000095663A (ja) | 植物抽出物を含有する外用剤 | |
| EP0345082A2 (de) | Wirkstoff zur Unterdrückung der Bildung eines Enzyms | |
| JPS60202806A (ja) | 色白化粧料 | |
| JPH05186324A (ja) | 美白化粧料 | |
| JPH05320039A (ja) | 美白化粧料 | |
| KR100389983B1 (ko) | 알부틴과 글루코시다제를 유효 성분으로 하는 미백제 | |
| JPH03275613A (ja) | 皮膚外用剤 | |
| JP4906179B2 (ja) | 皮膚外用剤 | |
| JP2003137714A (ja) | 化粧用組成物又は医薬用組成物 | |
| JP2000344653A (ja) | 活性酸素消去剤及び皮膚化粧料 | |
| CN114948789A (zh) | 一种具有高效抗蓝光功效的sod组合物及其制备方法 | |
| EP0345081A2 (de) | Wirkstoff zur Unterdrückung der Bildung eines Enzyms | |
| KR101305691B1 (ko) | 셀루릭서를 함유하는 항노화용 조성물 | |
| JP4726505B2 (ja) | 皮膚外用剤及び皮膚の美白方法 | |
| JP4610705B2 (ja) | 皮膚外用剤 | |
| JPH02273608A (ja) | 色白化粧料 | |
| JPH04187618A (ja) | 皮膚外用剤 | |
| JPS6236307A (ja) | 色白化粧料 | |
| JPH05509291A (ja) | フェニルアミン系脱色素、抗黒色腫剤 | |
| RU2096032C1 (ru) | Косметическое средство | |
| JP4804729B2 (ja) | 末梢血行改善用組成物 |